Patent · US Active

Piperazine derivatives useful as CCR5 antagonists

US7825121B2 · kind B2 · utility

1Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2005
Grant dateNov 2, 2010
Priority date—
Expiry dateNov 25, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H17/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The use of CCR5 antagonists of the formulaor a pharmaceutically acceptable salt thereof, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.